Volume 20, Number 6—June 2014
Streptococcus suis Infection and Malignancy in Man, Spain
To the Editor: Streptococcus suis is an emerging zoonotic agent. Human infection is associated with occupational exposure to swine. Affected persons are usually, but not always, healthy (1,2). Immunosuppressive conditions can predispose persons to S. suis infection, and cancer has classically been associated as a risk factor for S. suis infection (1,2). Nevertheless, the actual number of reported cases is low (2–7). We describe a severe case of S. suis infection in a man who had not been exposed to swine but for whom disseminated cancer was diagnosed 5 months after the infection.
In 2012, a 57-year-old alcoholic man from Spain, who had no other medical conditions and no contact with animals sought care for headache and vomiting for 24 hours. He reported a 4-day history of fever and a painful right shoulder. At admission, temperature was 38.9°C, blood pressure 180/100 mm Hg, heart rate 68 beats/min, and respiratory rate 24 breaths/min. Neck stiffness and lethargic mental status were noted.
Laboratory tests revealed the following values: leukocytosis of 14 × 109 (reference range 3.9–10 × 109) cells/L with 90.4% neutrophils, platelets 100×109 (reference 135–333 × 109) cells/L, hemoglobin 16 (reference 12.6–16.6) g/dL, creatinine 131 (reference 0–111) μmol/L, and C-reactive protein 243 (reference 0–5) mg/L. Lumbar puncture yielded turbid cerebrospinal fluid (CSF), with high opening pressure (>32 cm H2O), pleocytosis (0.4 × 109 leukocytes/L; 88% neutrophils), high protein level (70 [reference range 15–45] mg/dL) and a low glucose level (<0.3 [reference 2.2–4.1] mmol/L). CSF showed gram-positive cocci in chains. Cefotaxime, dexamethasone, and mannitol were administered. After septic shock and respiratory insufficiency developed, the patient was transferred to the intensive care unit.
Streptococcus spp. grew in blood and CSF cultures. Although initially misidentified as S. bovis, the pathogen was confirmed as S. suis by sequence analysis of the 16S rRNA gene. Multilocus sequence typing (http://ssuis.mlst.net) identified this isolate as sequence type (ST) 3.
The patient was transferred to the medical ward 18 days after admission. Neurologic examination demonstrated vestibular ataxia, hearing loss, and diplopia resulting from cranial nerve VI palsy. Furthermore, a diagnosis of subacromial/subdeltoid bursitis led to arthroscopic debridement. Ceftriaxone was administered for 4 weeks. Results of abdominal computed tomography and echocardiogram were within normal limits. Because the Streptococcus organism was initially identified as S. bovis, colonoscopy and assessment of tumor markers were also requested; results were within normal limits.
After the patient was discharged (4 weeks after admission), diplopia and the shoulder mobility limitation completely resolved, but bilateral deafness and ataxia persisted. Five months later, the patient was readmitted for severe hypercalcemia. Positron-emission and computed tomography revealed liver, lung, and bone metastases. Tumor markers were elevated (carcinoembryonic antigen 4,152 [reference range 0–4.3] μg/L; monoclonal antibody CA-19–1 9,233 [0–39] U/mL). The patient died of multiorgan failure 21 days after admission. Necropsy revealed a disseminated esophageal adenocarcinoma.
S. suis is an encapsulated gram-positive, catalase-negative facultative anaerobe coccus, positive for Lancefield group antigens R-S or T. This pathogen of swine is infrequently transmitted to humans (1–3,6); recently, however, the number of S. suis cases in humans has increased substantially. Most cases have been reported in Europe and Southeast Asia, where pig farming is intensive (1). Although cases are usually sporadic, 2 outbreaks in China (1998 and 2005) caused a substantial number of deaths. Exposure to infected pigs was demonstrated for almost all patients. However, some patients had not been exposed to animals (1,2,4). S. suis can be an opportunistic pathogen in immunocompromised persons (1,2). Splenectomy is a well-established risk factor. Other predisposing factors are alcoholism, heart disease, and diabetes (1,4,5).
Although cancer is accepted as a risk factor (1,2), the reported number of cases with associated malignancy is quite low (Table). For all cases except one, cancer was diagnosed before or during the episode of infection. A primary adrenal lymphoma was diagnosed 1 year after S. suis meningitis (6), but probably an underlying defect in humoral immunity was already present. The patient reported here probably had subclinical malignancy at the time of infection. Although we cannot rule out a spurious relationship between cancer and infection, we believe that malignancy, in combination with the patient’s alcoholism, led to an immunosuppressed condition that facilitated the development of infection.
S. suis leads to a wide spectrum of clinical manifestations, meningitis being the most common (1–3,6–8). A higher frequency of sensorineural hearing loss is characteristic of S. suis meningitis (1). In the patient reported here, meningitis was complicated by permanent deafness, ataxia, and transient diplopia; to our knowledge, only 2 other cases complicated by diplopia have been reported (8,9).
S. suis ST3 belongs to ST clonal complex 1 and is associated with serotype 2 (http://ssuis.mlst.net). Although clonal complex 1 accounts for most S. suis infections in humans (1,10), genotype ST3 is extremely rare. To our knowledge, only 1 other human case of S. suis ST3 infection has been reported, also in Spain (10).
The patient reported here had severe S. suis infection with no prior exposure to swine but with undiagnosed neoplasia. In patients with no exposure to swine, we recommend searching for other predisposing factors, such as malignancy or other immunodeficiencies.
We thank Michael Maudsley for revising the English-language manuscript.
S.G.-Z. is supported by a grant from the Instituto de Salud Carlos III (FIS PI11/00164). J.L.-T. is supported by a grant from the Instituto de Salud Carlos III (FI09/00943).
- Wertheim HF, Nghia HD, Taylor W, Schultsz C. Streptococcus suis: an emerging human pathogen. Clin Infect Dis. 2009;48:617–25.
- Manzin A, Palmieri C, Serra C, Saddi B, Princivalli MS, Loi G, Streptococcus suis meningitis without history of animal contact, Italy. Emerg Infect Dis. 2008;14:1946–8.
- Voutsadakis IA. Streptococcus suis endocarditis and colon carcinoma: a case report. Clin Colorectal Cancer. 2006;6:226–8 .
- Ma E, Chung PH, So T, Wong L, Choi KM, Cheung DT, Streptococcus suis infection in Hong Kong: an emerging infectious disease? Epidemiol Infect. 2008;136:1691–7.
- Wangkaew S, Chaiwarith R, Tharawichitkul P, Supparatpinyo K. Streptococcus suis infection: a series of 41 cases from Chiang Mai University Hospital. J Infect. 2006;52:455–60 .
- Yen MY, Liu YC, Wang JH, Chen YS, Wang YH, Cheng DL. Streptococcus suis meningitis complicated with permanent perceptive deafness: report of a case. J Formos Med Assoc. 1994;93:349–51 .
- Arends JP, Zanen HC. Meningitis caused by Streptococcus suis in humans. Rev Infect Dis. 1988;10:131–7 .
- Geffner Sclarsky DE, Moreno Muñoz R, Campillo Alpera MS, Pardo Serrano FJ, Gómez Gómez A, Martínez-Lozano MD. Streptococcus suis meningitis. [in Spanish]. Med Interna. 2001;18:317–8.
- Meecham JS, Worth RC. Persistent diplopia following Streptococcus suis type 2 meningitis. J R Soc Med. 1992;85:579–80 .
- Vela AI, Aspiroz C, Fortuño B, Tirado G, Sierra J, Martinez R, Meningitis caused by an unusual genotype (ST3) of Streptococcus suis. Infection. 2013;41:701–3 .
Suggested citation for this article: Gómez-Zorrilla S, Ardanuy C, Lora-Tamayo J, Cámara J, García-Somoza D, Peña C, et al. Streptococcus suis infection and malignancy in man, Spain [letter]. Emerg Infect Dis [Internet]. 2014 Jun [date cited]. http://dx.doi.org/10.3201/eid2006.131167
Please use the form below to submit correspondence to the authors or contact them at the following address:
Silvia Gómez-Zorrilla, Infectious Diseases Service, Hospital Universitario de Bellvitge, Bellvitge Biomedical Research Institute, Feixa Llarga s/n 08907, Hospitalet de Llobregat, Barcelona, Spain
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: May 19, 2014
- Page last updated: May 19, 2014
- Page last reviewed: May 19, 2014
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)